Açaí seed extract mitigates intestinal and hypothalamic alterations in obese mice
Molecular and Cellular Endocrinology · 2025
DOI: 10.1016/j.mce.2025.112574 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular and Cellular Endocrinology, 2025. Verfasst von Bernardo Junqueira de Moraes Arnoso und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, Institute of Biology, Rio de Janeiro State University, Rio de Janeiro, RJ, Brazil. Hauptthemen laut MEDLINE: Plant Extracts, Hypothalamus, Obesity, Seeds. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 119 Literaturangaben. Gefördert von: Coordination of Higher Education Personnel Improvement, National Council for Scientific and Technological Development, Carlos Chagas Filho Foundation for Research Support of Rio de Janeiro State.
Abstract (Originalsprache)
Obesity is a significant health concern, significantly contributing to increased morbidity and mortality by disrupting multiple physiological systems. It is strongly associated with metabolic dysfunctions, including impaired glycemic homeostasis, compromised intestinal barrier integrity, and gut microbiota imbalances, all exacerbating the risk of chronic diseases. The hydroalcoholic extract of açaí seeds (ASE), rich in phenolic compounds, has demonstrated beneficial effects on obesity and hyperglycemia; however, its impacts on gut health and gut-hypothalamus communication remain unclear. This study aimed to investigate the therapeutic effect of ASE in intestinal and hypothalamic alterations associated with obesity and compare it with Metformin. Male C57BL/6 mice were fed a high-fat or standard diet for 14 weeks. The ASE (300 mg/kg/day) and Metformin (300 mg/kg/day) treatments started in the tenth week until the fourteenth week, totaling four weeks of treatment. Our data show that the treatment with ASE and Metformin reduced body weight, ameliorated lipid profile, hyperglycemia, and plasma hyperleptinemia, and decreased the oxidative damage in the gut by reducing immunostaining of 8-isoprostane and NOX-4 expression, and improved the intestinal parameters and hypothalamic gene expression. Obesity-induced dysbiosis in the HF group was marked by reduced Proteobacteria and elevated LPS plasma levels, which were improved by treatments with ASE and Metformin. These findings suggest that ASE and Metformin are promising strategies to counteract the adverse effects of obesity on intestinal health and gut-hypothalamus communication, though they act through distinct mechanisms. Therefore, we can suggest that ASE is a promising natural product for treating the intestinal alterations associated with obesity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacology, Institute of Biology, Rio de Janeiro State University, Rio de Janeiro, RJ, Brazil.
- Neurogenetics Laboratory, Department of Pharmacology, Institute of Biology, Rio de Janeiro State University, Rio de Janeiro, RJ, Brazil.
- Department of Basic and Experimental Nutrition, Institute of Nutrition, Rio de Janeiro State University, Rio de Janeiro, Brazil.
- Nutrition School, Federal University of Ouro Preto, Ouro Preto, Brazil.
- Department of Pharmacology, Institute of Biology, Rio de Janeiro State University, Rio de Janeiro, RJ, Brazil. Electronic address: crysac84@yahoo.com.br.
Förderung
- Coordination of Higher Education Personnel Improvement
- National Council for Scientific and Technological Development
- Carlos Chagas Filho Foundation for Research Support of Rio de Janeiro State
Zitieren
APA
de Moraes Arnoso, B. J., de Araújo, C. A., Ramundo, G. D., de Bem, G. F., Ognibene, D. T., Fontes-Dantas, F. L., Martins, B. C., Daleprane, J. B., de Souza, M. O., Resende, A. C., & da Costa, C. A. (2025). Açaí seed extract mitigates intestinal and hypothalamic alterations in obese mice. Molecular and Cellular Endocrinology. https://doi.org/10.1016/j.mce.2025.112574
Vancouver
de Moraes Arnoso BJ, de Araújo CA, Ramundo GD, de Bem GF, Ognibene DT, Fontes-Dantas FL, et al. Açaí seed extract mitigates intestinal and hypothalamic alterations in obese mice. Molecular and Cellular Endocrinology. 2025. doi:10.1016/j.mce.2025.112574
BibTeX
@article{deMoraesArnoso2025,
author = {de Moraes Arnoso, Bernardo Junqueira and de Araújo, Caroline Alves and Ramundo, Giovana Dias and de Bem, Graziele Freitas and Ognibene, Dayane Teixeira and Fontes-Dantas, Fabricia Lima and Martins, Bruna Cadete and Daleprane, Julio Beltrame and de Souza, Melina Oliveira and Resende, Angela Castro and da Costa, Cristiane Aguiar},
title = {Açaí seed extract mitigates intestinal and hypothalamic alterations in obese mice},
journal = {Molecular and Cellular Endocrinology},
year = {2025},
doi = {10.1016/j.mce.2025.112574}
}
EUVIMED